Caveolin and MAP kinase interaction in angiotensin II preconditioning of the myocardium
- PMID: 17760840
- PMCID: PMC3823257
- DOI: 10.1111/j.1582-4934.2007.00067.x
Caveolin and MAP kinase interaction in angiotensin II preconditioning of the myocardium
Retraction in
-
Retracted: Caveolin and MAP kinase interaction in angiotensin II preconditioning of the myocardium.J Cell Mol Med. 2012 Oct;16(10):2547. doi: 10.1111/j.1582-4934.2012.01619.x. J Cell Mol Med. 2012. PMID: 23189334 Free PMC article. No abstract available.
Abstract
Angiotensin II (Ang II) has been found to exert preconditioning (PC)-like effect in mammalian hearts. The present investigation reported for the first time a unique mitogen activated protein (MAP) kinase signalling in Ang II PC of the heart involving lipid rafts, which generated a survival signal by differentially associating MAP kinases with caveolin. A group of rat hearts was treated with Ang II in the absence or presence of NADPH oxidase inhibitor, apocynin or a cell permeable reactive oxygen species (ROS) scavenger, N-acetyl-cysteine (NAC). Ang II pre-treatment improved post-ischaemic ventricular recovery, myocardial infraction and decreased the number of cardiomyocyte apoptosis indicating PC effect of Ang II. Both apocynin and NAC abolished the PC ability of Ang II. In Ang II treated heart, there was a decreased association of p38MAPKbeta & extracellular-signal regulated kinase (ERK) 1/ 2 (anti-death signalling component) with caveolin while there was an increased association of p38MAPKalpha & Jun N-terminal kinase (JNK) (death signalling component) indicating reduced amount of death signal components and increased amount of anti-death signalling components being available to the Ang II treated heart to generate a survival signal, which was reversed with NAC or apocynin. The survival signal was also demonstrated by increased phosphorylation of serine/threonine-protein kinase B (AKT) and enhanced induction of expression of Bcl-2 during Ang II PC and its reversal with NAC & apocynin treated heart.
Figures




Similar articles
-
Angiotensin preconditioning of the heart: evidence for redox signaling.Cell Biochem Biophys. 2006;44(1):103-10. doi: 10.1385/CBB:44:1:103. Cell Biochem Biophys. 2006. PMID: 16456238
-
Redox regulation of angiotensin II preconditioning of the myocardium requires MAP kinase signaling.J Mol Cell Cardiol. 2006 Aug;41(2):248-55. doi: 10.1016/j.yjmcc.2006.03.009. Epub 2006 May 11. J Mol Cell Cardiol. 2006. Retraction in: J Mol Cell Cardiol. 2012 Nov;53(5):742. doi: 10.1016/j.yjmcc.2012.08.018. PMID: 16697003 Retracted.
-
Generation of survival signal by differential interaction of p38MAPKalpha and p38MAPKbeta with caveolin-1 and caveolin-3 in the adapted heart.J Mol Cell Cardiol. 2007 Jan;42(1):206-13. doi: 10.1016/j.yjmcc.2006.08.118. Epub 2006 Oct 25. J Mol Cell Cardiol. 2007. PMID: 17069850 Free PMC article.
-
Angiotensin II: a regulator of cardiomyocyte function and survival.Front Biosci (Landmark Ed). 2009 Jun 1;14(13):5118-33. doi: 10.2741/3590. Front Biosci (Landmark Ed). 2009. PMID: 19482608 Review.
-
Caveolins in cardioprotection - translatability and mechanisms.Br J Pharmacol. 2015 Apr;172(8):2114-25. doi: 10.1111/bph.13009. Epub 2015 Jan 13. Br J Pharmacol. 2015. PMID: 25377989 Free PMC article. Review.
Cited by
-
Gene expression profile of rat left ventricles reveals persisting changes following chronic mild exercise protocol: implications for cardioprotection.BMC Genomics. 2009 Jul 30;10:342. doi: 10.1186/1471-2164-10-342. BMC Genomics. 2009. PMID: 19643001 Free PMC article.
-
From rapid to delayed and remote postconditioning: the evolving concept of ischemic postconditioning in brain ischemia.Curr Drug Targets. 2012 Feb;13(2):173-87. doi: 10.2174/138945012799201621. Curr Drug Targets. 2012. PMID: 22204317 Free PMC article. Review.
-
Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.Physiol Rev. 2010 Oct;90(4):1507-46. doi: 10.1152/physrev.00054.2009. Physiol Rev. 2010. PMID: 20959622 Free PMC article. Review.
-
Lipid raft in cardiac health and disease.Curr Cardiol Rev. 2009 May;5(2):105-11. doi: 10.2174/157340309788166660. Curr Cardiol Rev. 2009. PMID: 20436850 Free PMC article.
-
Myocardial AKT: the omnipresent nexus.Physiol Rev. 2011 Jul;91(3):1023-70. doi: 10.1152/physrev.00024.2010. Physiol Rev. 2011. PMID: 21742795 Free PMC article. Review.
References
-
- Ferreira AJ, Santos RA, Almeida AP. Angiotensin: cardio protective effect in myocardial ischemia/reperfusion. Hypertension. 2001;38:665–8. - PubMed
-
- Sharma A, Singh M. Possible mechanism of cardio protective effect of angiotensin preconditioning in isolated rat heart. Eur J Pharmacol. 2000;406:85–92. - PubMed
-
- Sharma A, Singh M. Effect of ethylisopropyl amiloride, a Na + -H + exchange inhibitor, on cardio protective effect of ischemic and angiotensin preconditioning. Mol Cell Biochem. 2000;214:31–8. - PubMed
-
- Nakano A, Miura T, Ura N, Suzuki K, Shimamoto K. Role of angiotensin II type I receptor in preconditioning against infarction. Coronary Artery Dis. 1997;8:343–50. - PubMed
-
- Diaz RJ, Wilson GJ. Selective blockade of AT1 angiotensin II receptors abolishes ischemic preconditioning in isolated rabbit hearts. J Mol Cell Cardiol. 1997;29:129–39. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous